Fox-Fordyce disease (FFD) or 'apocrine miliaria' is a rare benign skin condition characterized by obstruction of the apocrine sweat gland. Treatment is generally unsatisfactory. A 15-year-old girl presented with intensely pruritic lesions on her axillae, chest and groin. Histology from an axillary skin biopsy confirmed FFD. The patient was commenced on pimecrolimus cream twice daily for three months and then once daily for a further three months. After a month she had marked improvement of her symptoms. By three months, the papules had flattened. The lesions remained healed at follow up nine months after completing therapy. Pimecrolimus is a safe and easy to use option and we suggest that it may be considered as first-line therapy for FFD.Keywords: Fox-Fordyce disease, apocrine miliaria, pimecrolimus, Elidel, treatment.Fox-Fordyce disease (FFD), or 'apocrine miliaria' is a rare benign skin condition characterized by obstruction of the apocrine sweat gland [1]. Treatment is generally unsatisfactory. We report a patient with FFD successfully treated with pimecrolimus.The pathogenesis of FFD is unclear but involves an initial keratin plug in the infundibulum of the hair follicle that then extends into the apocrine sweat duct. Intraepidermal parts of the apocrine duct rupture and microvesicles form. Acanthosis, spongiosis, dermal mucin and an inflammatory infiltrate result [2].A 15-year-old girl presented with intensely pruritic lesions on her axillae, chest and groin. On examination, she had follicular papules and pigmentation confined to these sites (Fig. 1). She had been previously unsuccessfully treated with moderate potency topical steroids, antifungals, tretinoin and oral antibiotics prescribed by her GP. Histology from an axillary skin biopsy confirmed FFD. The patient was commenced on pimecrolimus cream twice daily for three months and then once daily for a further three months. After a month she had marked improvement of her symptoms. By three months, the papules had flattened, the pruritus had lessened and the postinflammatory hyperpigmentation was not as prominent (Fig. 2). The lesions remained healed at follow up nine months after completing therapy.Fox-Fordyce disease runs a prolonged course. As well as the discomfort associated with pruritus, the lesions are cosmetically disfiguring. Case reports describe treatments with limited efficacy or associated with side effects that outweigh the benefits of treatment. Treatments include topical clindamycin, corticosteroids, tretinoin, benzoyl peroxide, oral isotretinoin, oral contraceptives, ultraviolet *Address correspondence to this author at the Department of Dermatology, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK; E-mail: nilesh.morar@chelwest.nhs.uk Fig. (1). Follicular papules and pigmentation seen in the left axilla of the patient pre-treatment.
A 79-year-old Indian man presented with a warty growth on his frontal scalp. On physical examination, he was also found to have a cluster of approximately 20 deeply pigmented macules over the right parietooccipital scalp ( Fig. 1a) As the patient had been unaware of these macules, he was unable to state when they had first developed. There was no relevant medical history or any history of preceding injury. The patient was not taking any systemic drugs, and had not applied any topical preparations to the affected area. The wart was curetted, and a 3-mm punch biopsy was taken from one of the pigmented macules for histopathological examination. Histopathological findingsThe warty growth was shown histologically to be a viral wart. On histological examination of the punch biopsy taken from the pigmented macule, spindle, bipolar, and heavily pigmented cells were seen in the dermis, with no evidence of atypia (Fig. 2).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.